Shed vs bmiMD: coaching and name-brand vs low-cost tirzepatide
Shed vs bmiMD comes down to a tradeoff: Shed pairs name-brand and compounded GLP-1 options with continuous coaching and a 2-minute approval assessment, while bmiMD focuses on compounded tirzepatide with multi-month pricing and free shipping. Quick verdict: choose Shed if you want integrated coaching and the option of FDA-approved name-brand medication; choose bmiMD if your priority is lower long-term monthly cost on compounded tirzepatide.
Start Shed 2-minute assessment
Shed vs bmiMD: 5 key differences at a glance
| Criteria | Shed | bmiMD |
|---|---|---|
| Medication types | Name-brand and compounded GLP-1 options | Compounded tirzepatide (GLP-1/GIP) |
| Coaching and clinician access | Continuous coaching integrated into treatment | 24/7 clinician access; online refills |
| Pricing model | Compounded semaglutide starting at $199/month; name-brand pricing provided after intake; 10% off first month | Tiered monthly pricing: $179 month-to-month; $159 3-month; $149 6-month; $139 12-month |
| Shipping and commitments | Medication shipped after clinician review; limited-time 10% off first month | Free subscription shipping; lowest price requires 12-month commitment |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Medication options: name-brand plus compounded vs compounded tirzepatide
Shed offers both FDA-approved name-brand GLP-1s and compounded alternatives, letting patients choose between branded options and compounded semaglutide or tirzepatide. bmiMD centers on compounded tirzepatide (GLP-1/GIP) with the same price at every dose. Both providers note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Coaching and clinical support compared
Shed integrates continuous coaching into the treatment plan rather than issuing a prescription alone, positioned for patients who want behavioral support alongside medication. bmiMD emphasizes 24/7 clinician access and online refills. If ongoing behavioral coaching is your priority, Shed documents coaching bundled with medication. If you prioritize clinician availability and refill convenience, bmiMD highlights 24/7 access and delivery.
Explore Shed coaching and options
Pricing and billing: immediate vs multi-month savings
Shed lists compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month, with name-brand pricing provided after intake; new patients get 10% off their first month. bmiMD publishes specific tiered pricing: $179 month-to-month, $159 for three months, $149 for six months, and $139 for a 12-month plan, with free shipping. bmiMD notes the lowest price requires a 12-month commitment and advises confirming total prepaid charge and eligibility.
Fulfillment, shipping, and enrollment speed
Shed uses a 2-minute online assessment to check eligibility, followed by clinician review before prescriptions are issued and medication shipped. bmiMD advertises quick turnaround, online refills, and free subscription shipping on every order. Both require a licensed clinician to determine whether treatment is medically appropriate.
See bmiMD pricing tiers and shipping
Who is each provider best for?
Shed is best for patients who want more than a prescription: access to name-brand GLP-1 alongside compounded options, continuous coaching integrated into treatment, and a fast 2-minute eligibility assessment. bmiMD is best for people focused on lower long-term monthly cost for compounded tirzepatide with clear multi-month pricing and free shipping, provided they confirm state availability and any prepaid commitments.
Check bmiMD enrollment details
Final thoughts on Shed vs bmiMD
Both Shed and bmiMD offer compounded medication routes and require clinician review. The main differences are Shed’s combination of name-brand options plus integrated coaching and a 2-minute assessment versus bmiMD’s tiered multi-month pricing, free shipping, and 24/7 clinician access. The regulatory note that compounded medications are not FDA-approved applies to both.
Choose Shed if…
You want the option of FDA-approved name-brand GLP-1 plus compounded alternatives, continuous coaching integrated with treatment, a fast 2-minute approval assessment, and a 10% off first month offer.
Choose bmiMD if…
You prioritize lower long-term monthly pricing for compounded tirzepatide, free subscription shipping, clear multi-month billing options, and 24/7 clinician access.